Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125224071 | 12522407 | 1 | I | 20160621 | 20160701 | 20160701 | EXP | CA-MYLANLABS-2016M1027130 | MYLAN | RUZYCKI S, YAREMA M, DUNHAM M, SADRZADEH H, TREMBLAY A. INTRANASAL FENTANYL INTOXICATION LEADING TO DIFFUSE ALVEOLAR HEMORRHAGE. J-MED-TOXICOL 2016;12(2):185-188. | 0.00 | Y | 0.00000 | 20160630 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125224071 | 12522407 | 1 | PS | FENTANYL. | FENTANYL | 1 | Nasal | 76258 | |||||||||||
| 125224071 | 12522407 | 2 | C | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 125224071 | 12522407 | 3 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125224071 | 12522407 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125224071 | 12522407 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125224071 | 12522407 | Drug abuse | |
| 125224071 | 12522407 | Pulmonary alveolar haemorrhage | |
| 125224071 | 12522407 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |